Inventor
RUDOLF KLAUS
DE87 patents
⚠️ This page may combine multiple inventors who share the name “RUDOLF KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
18 patentsUS7479488B2Jan 20, 2009
Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT63 citations97
US7696209B2Apr 13, 2010
CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT24 citations92
US7375104B2May 20, 2008
Long acting beta-2-agonists and their use as medicaments
BOEHRINGER INGELHEIM INT14 citations92
US7279471B2Oct 9, 2007
Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT48 citations92
US7160882B2Jan 9, 2007
Long acting β-2-agonists and their use as medicaments
BOEHRINGER INGELHEIM INT27 citations92
US7807666B2Oct 5, 2010
CGRP antagonists
BOEHRINGER INGELHEIM INT9 citations84
US7592373B2Sep 22, 2009
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
BOEHRINGER INGELHEIM INT13 citations84
US7205294B2Apr 17, 2007
Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT14 citations84
US7439237B2Oct 21, 2008
Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT8 citations74
US10071974B2Sep 11, 2018
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT2 citations73
US7491717B2Feb 17, 2009
Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT6 citations73
US7632834B2Dec 15, 2009
Long acting beta-2-agonists and their use as medicaments
BOEHRINGER INGELHEIM INT2 citations63
US7625886B2Dec 1, 2009
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT3 citations63
US7582625B2Sep 1, 2009
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT3 citations63
US7579341B2Aug 25, 2009
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT3 citations63
US7528129B2May 5, 2009
CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT3 citations63
US10577336B2Mar 3, 2020
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT1 citations62
USRE47493EJul 9, 2019
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
BOEHRINGER INGELHEIM INT1 citations62
BOEHRINGER INGELHEIM PHARMA
12 patentsUS6521609B1Feb 18, 2003
Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushes
BOEHRINGER INGELHEIM PHARMA122 citations98
US6313097B1Nov 6, 2001
Antagonists of calcitonin gene-related peptide
BOEHRINGER INGELHEIM PHARMA93 citations98
US7056916B2Jun 6, 2006
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA43 citations96
US7727984B2Jun 1, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA9 citations84
US7230001B1Jun 12, 2007
Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
BOEHRINGER INGELHEIM PHARMA16 citations84
US7351719B2Apr 1, 2008
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
BOEHRINGER INGELHEIM PHARMA16 citations83
US7452911B2Nov 18, 2008
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
BOEHRINGER INGELHEIM PHARMA10 citations82
US7786111B2Aug 31, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA5 citations73
US7026312B2Apr 11, 2006
Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
BOEHRINGER INGELHEIM PHARMA8 citations73
US8044046B2Oct 25, 2011
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA2 citations62
US7595312B2Sep 29, 2009
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA3 citations62
US7538115B2May 26, 2009
Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
BOEHRINGER INGELHEIM PHARMA4 citations62
THOMAE GMBH DR K
8 patentsUS6344449B1Feb 5, 2002
Modified aminoacids, pharmaceuticals containing these compounds and method for their production
THOMAE GMBH DR K158 citations99
US6114390ASep 5, 2000
Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
THOMAE GMBH DR K35 citations92
US5962530AOct 5, 1999
Amino acid derivatives, medicaments containing said compounds and methods of producing them
THOMAE GMBH DR K23 citations92
US5011836AApr 30, 1991
Agents for the treatment of acute and chronic obstructive respiratory passage diseases
THOMAE GMBH DR K20 citations82
US5807875ASep 15, 1998
Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
THOMAE GMBH DR K13 citations73
US5616620AApr 1, 1997
Amino acid derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of obesity
THOMAE GMBH DR K13 citations72
US5468766ANov 21, 1995
1,5,6,7-tetrahydro-4H-indazol-4-ones
THOMAE GMBH DR K3 citations63
US5641772AJun 24, 1997
Condensed diazepinones, processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation
THOMAE GMBH DR K2 citations62
CENTREXION THERAPEUTICS CORP
3 patentsUS10166214B2Jan 1, 2019
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP4 citations83
US9789082B2Oct 17, 2017
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP5 citations83
US10675268B2Jun 9, 2020
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP2 citations72
GRAUERT MATTHIAS
2 patentsNOVO NORDISK
1 patentGOTTSCHLING DIRK
1 patentKARL THOMAS GMBH
1 patentNOVO NORDISK AS
1 patentSTENKAMP DIRK
1 patentCT XION THERAPEUTICS CORP
1 patentGNAMM CHRISTIAN
1 patentShowing the top 50 of 87 patents by PatentIndex Score.